Diabetes-induced coronary vascular dysfunction involves increased arginase activity - Wikidata - wikimedia - TriplyDB

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

http://www.wikidata.org/entity/Q41817278

about

The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice Arginase promotes endothelial dysfunction and hypertension in obese rats Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.Diabetes-induced inhibition of voltage-dependent calcium channels in the retinal microvasculature: role of spermine.Diabetic retinopathy: current management and experimental therapeutic targets.Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy.Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis Vascular dysfunction in retinopathy-an emerging role for arginase MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging.Mitochondrial targeting by dichloroacetate improves outcome following hemorrhagic shock.Thrombin induces endothelial arginase through AP-1 activation.Endothelial arginine resynthesis contributes to the maintenance of vasomotor function in male diabetic mice.Estrogen and oxidative stress: A novel mechanism that may increase the risk for cardiovascular disease in women.Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice.Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity.The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo.Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007 Novel therapeutic strategies for adult obese asthmatics.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders.Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats Increased erythrocytes by-products of arginine catabolism are associated with hyperglycemia and could be involved in the pathogenesis of type 2 diabetes mellitus.Arginase in retinopathy.Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.Recent advances in arginine metabolism: roles and regulation of the arginases.Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

P2860

Q26774795-25F3F321-2F36-4314-86A9-BF63D7FCFFF1 Q26859449-081B15D5-26E3-4B8B-8478-3EBBC6D10B3A Q26991946-A151355A-B5D1-4A53-AEF3-7668CAC0BE6E Q28073279-B1F6D898-2282-4652-8E60-E0CDEB756B4B Q28260398-44E95835-E308-4C9A-B91B-032592DB1386 Q28386564-A3CEFE36-57E8-43D0-BB08-78A96AC37FF7 Q28386943-A34DD3C5-62B2-4895-947F-0E86DE3406FB Q28397692-A0ADFC02-607B-4F2B-B315-CFE5FBF2A05E Q30481313-92077C50-EB31-4C1E-92BE-F770E1EC296C Q30498932-59A213CA-BEEF-44C6-B67C-29452E773596 Q33403016-78E6A110-8B6E-4401-A56C-582B85FE6CFD Q33526952-AC909209-5824-4706-A766-1C2D56DFB191 Q33569387-40A17CBE-B9FB-443A-9F86-721C71B37D54 Q33625727-DA42F0FD-3E40-4B92-BD95-5F0F7EE07E4A Q33750015-E455CC49-3BA8-4973-B1CF-8567E1771D09 Q33752927-492F5286-A509-4451-8AB1-5F8F134D767B Q33783523-5DBA71EB-B008-41C4-BE94-61D8556BAEC5 Q33916398-90417FBD-EECE-46BF-961D-D40994872C07 Q33936813-3504FB1E-D46E-44E0-A7B6-448F68B88EF3 Q33946024-D47B1BB3-ABE5-4CD9-B2AE-97AF0AF47B3D Q33979991-21901D66-12D6-47CA-AB9A-4E64F85CD825 Q34070745-D5A369AA-F205-4166-8B8E-8E73CE3ABD7F Q34159297-3E78DEF9-B0EC-4B0D-A055-6D6EAB88ED96 Q34290008-A1011444-4793-4DE6-A9F2-DEC096DAA008 Q34362144-F1E35830-5C44-4F7A-BC73-55DE66762733 Q34364451-182ED9F5-FB55-42F8-8259-4D15C7C17ABC Q34376157-A4A3AEFD-F273-4B1B-9D2F-8035C02E4903 Q34406933-6D5725F6-A1FE-42F3-AA99-8CD0B5F5CBD5 Q34465434-A3FEE0FE-7238-4E36-BD5D-664E2EFC0B03 Q34509144-A66102A3-F30A-457D-B5A2-03BAFB016E90 Q34664336-8D6163AC-E502-4842-A8BB-B37A154A15BC Q34720332-DAD10DF7-C18A-4FA8-819B-2943B04EEC68 Q34755179-E403265F-BDCA-4F2F-B583-A4A6902D06F7 Q34796091-715A7248-8EFC-4BB1-A4B7-0C81DC5EDB23 Q34800913-92A187D7-94C6-4D37-A747-A9419A3C9190 Q34934327-AA114348-F6E7-4AED-B733-F6B292AE2353 Q34973749-AB579354-632C-4ED5-AECC-A0C7572F3108 Q34979275-F89FFFCA-5199-4997-A78E-AAA9B59F992C Q34985733-927A7716-B41A-4D67-A2E1-8973406C4D90 Q35050926-10A0280A-BC21-42E9-9D61-68C2E3F08D33

P2860

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

http://www.wikidata.org/entity/Q41817278

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

@en

type

label

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

@en

prefLabel

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

@en

P1433

Q41817278-808CB612-0A6C-414E-87DC-E496AC7262E3

P1476

Q41817278-B283FA56-595F-4F4E-8FC7-1DF6F8BEA3EF

P2093

Q41817278-4BFE0716-C8DB-456E-A881-F9A7A942C882

Q41817278-4DF729B0-69CA-4749-A93F-FA1EE2D39855

Q41817278-4E3F3C15-6F68-4519-A8D8-EC1C9BDDFD59

Q41817278-848DBA5E-308D-4469-8EDF-5003F4435926

Q41817278-BF053E81-E014-40A8-A652-F22405CA5AEF

Q41817278-E5CC1BB7-A3D2-4968-820C-0DE3C072BA12

Q41817278-F286788E-A31C-4DF9-BABC-84A37D9ACAF9

Q41817278-F6CC436A-5D45-42DD-AF71-B52CDADC34EB

P2860

Q41817278-09BAEDFC-E7AB-4F27-AC48-B7258840A42D

Q41817278-09CAA33D-2C3D-4E77-95C8-7A63CBE1E550

Q41817278-0FA8AAEC-31C8-4EF5-BEBC-5F3C18D52F59

Q41817278-137C1EA6-311E-4F5D-BFAF-E2BA4DBB920A

Q41817278-1847127D-4C8B-4F98-94D0-6DDF827AA46B

Q41817278-1ED1FB07-12FC-49C8-98F8-B2847E5612F7

Q41817278-22CB690F-C4DC-4219-A012-6CD7C11D1974

Q41817278-2A6CE61A-2B51-4168-B925-66244D718E6D

Q41817278-2F98CAEE-A5F9-4F31-AEB8-15EC577B5CB1

Q41817278-37457BF8-4BB7-4542-8CF5-B4B574616178

P304

Q41817278-DEF1F138-5A08-4F07-B169-9A6163FD74EE

P31

Q41817278-8F62FD05-B302-4A76-ABD6-A59ACE408E41

P356

Q41817278-F2D45287-B055-4DB7-B868-57010736994A

P433

Q41817278-61508B63-E13F-4857-B7AD-529B6B7E12EF

P478

Q41817278-D322888E-226F-446D-BD53-2EB24840FFEA

P577

Q41817278-8D9CD96A-14AD-44A4-9764-6BD1D83F9555

P698

Q41817278-B8EFAEB5-CCEB-4A17-9F5B-3595C98562E6

P932

Q41817278-DFAD1F08-59A6-4FD5-B7D6-5DE35778B83B

P356

CIRCRESAHA.107.155028

P1433

Circulation Research

P1476

Diabetes-induced coronary vascular dysfunction involves increased arginase activity

@en

P2093

Azza B El-Remessy

http://www.w3.org/2001/XMLSchema#string

Daniel H Platt

http://www.w3.org/2001/XMLSchema#string

Huda E Tawfik

http://www.w3.org/2001/XMLSchema#string

Manuela Bartoli

http://www.w3.org/2001/XMLSchema#string

Maritza J Romero

http://www.w3.org/2001/XMLSchema#string

Mohamed Labazi

http://www.w3.org/2001/XMLSchema#string

Robert W Caldwell

http://www.w3.org/2001/XMLSchema#string

Ruth B Caldwell

http://www.w3.org/2001/XMLSchema#string

P2860

Pleiotropic effects of statins

Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population

Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle

Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells

Cellular antioxidant effects of atorvastatin in vitro and in vivo.

Protein disregulation in red blood cell membranes of type 2 diabetic patients.

Mechanisms underlying endothelial dysfunction in diabetes mellitus.

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging.

Regulation of enzymes of urea and arginine synthesis.

P304

95-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.107.155028

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17967788

http://www.w3.org/2001/XMLSchema#string

P932

2822539

http://www.w3.org/2001/XMLSchema#string